<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There has been no large-scale population-based study on the relationship between <z:e sem="disease" ids="C0267830" disease_type="Disease or Syndrome" abbrv="">pyogenic liver abscesses</z:e> (<z:chebi fb="79" ids="53407">PLA</z:chebi>) and subsequent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To estimate <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk following a diagnosis of <z:chebi fb="79" ids="53407">PLA</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Based on Taiwan's National Health Insurance Research Database, 1257 patients with <z:chebi fb="79" ids="53407">PLA</z:chebi> without prior <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the period 1996-2008 were identified and followed-up </plain></SENT>
<SENT sid="3" pm="."><plain>The standard incidence ratio (SIR) of each <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was calculated as the number of observed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases arising among the <z:chebi fb="79" ids="53407">PLA</z:chebi> patients divided by the expected case number of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases according to the national <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> rates </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of the 1257 PLA patients identified, 598 (47.6%) had <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>After a median (±s.d.) follow-up of 3.33 ± 3.45 years, 186 were diagnosed with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including 56 <z:hpo ids='HP_0002896'>liver cancer</z:hpo>, 22 biliary tract <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and 40 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with <z:chebi fb="79" ids="53407">PLA</z:chebi> had a higher risk of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (SIR, 3.83; 95% CI, 3.30-4.42), <z:hpo ids='HP_0002896'>liver cancer</z:hpo> (SIR, 7.87; 95% CI, 5.94-10.21), <z:e sem="disease" ids="C0750952" disease_type="Neoplastic Process" abbrv="">biliary tract cancer</z:e> (SIR, 34.58; 95% CI, 21.67-52.36) and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (SIR, 5.27; 95% CI, 3.76-7.18) </plain></SENT>
<SENT sid="7" pm="."><plain>The highest SIRs of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, <z:hpo ids='HP_0002896'>liver cancer</z:hpo>, <z:e sem="disease" ids="C0750952" disease_type="Neoplastic Process" abbrv="">biliary tract cancer</z:e> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> occurred within 90 days of follow-up (360.82; 95% CI, 278.46-459.91, 257.28; 95% CI, 186.17-346.56, 1153.38; 95% CI 694.08-1801.24, and 52.63; 95% CI 25.2-96.8 respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0267830" disease_type="Disease or Syndrome" abbrv="">Pyogenic liver abscesses</z:e> may herald the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, especially hepato-biliary and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Further surveys should be conducted for the detection of occult <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in such patients </plain></SENT>
</text></document>